Newbridge Financial Reduces Altria Group Stake

Investment firm sells over 60,000 shares of tobacco giant in Q4 2025

Apr. 7, 2026 at 10:55am

Got story updates? Submit your updates here. ›

An extreme close-up of industrial banking equipment and machinery in muted greys, blues, and blacks, conceptually representing the institutional financial infrastructure behind tobacco stocks.A recent wave of institutional divestment from tobacco stocks signals shifting investor sentiment around the future of the traditional cigarette industry.Richmond Today

Newbridge Financial Services Group Inc. decreased its stake in Altria Group, Inc. (NYSE:MO) by 69.5% in the fourth quarter of 2025, according to a recent SEC filing. The firm sold 60,531 shares, leaving it with 26,571 shares worth $1.5 million at the end of the reporting period.

Why it matters

Altria Group is one of the largest tobacco companies in the U.S., and changes in institutional ownership can signal broader market sentiment around the stock and the industry. This move by Newbridge Financial suggests a potential shift in investor attitudes toward traditional tobacco firms amid ongoing public health and regulatory concerns.

The details

Newbridge Financial Services Group Inc. sold 60,531 shares of Altria Group during the fourth quarter of 2025, reducing its total position by 69.5%. The firm now holds 26,571 shares of the tobacco company's stock, valued at $1.5 million at the end of the reporting period.

  • Newbridge Financial filed its 13F report for Q4 2025 on April 7, 2026.
  • The firm sold the Altria Group shares during the fourth quarter of 2025.

The players

Newbridge Financial Services Group Inc.

An investment management firm that decreased its stake in Altria Group by over 69% in Q4 2025.

Altria Group, Inc.

A major U.S. tobacco company that owns the Philip Morris USA cigarette brand.

Got photos? Submit your photos here. ›

The takeaway

This reduction in Newbridge Financial's Altria Group holdings reflects broader uncertainty around the future of the traditional tobacco industry, as public health concerns and regulatory pressures continue to mount. Investors will be closely watching to see if other institutional investors follow suit in reducing their exposure to major cigarette manufacturers.